STOCK TITAN
  1. Home
  2. Sec-filings
  3. AME
  4. [Form 4] AMETEK INC/ Insider Trading Activity

AMETEK (NYSE: AME) SVP receives new stock and option awards

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

AMETEK Senior VP and Controller Robert Amodei received new equity awards. He was granted stock options for 1,130 shares of common stock at an exercise price of $212.77 per share. These options vest in three equal annual installments beginning on March 18, 2027 and expire on March 18, 2036.

Amodei also received 360 shares of common stock at $212.77 per share as restricted stock under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. Of these, 69 shares were withheld to cover taxes, with the remainder added to his direct holdings, which total 44,221 common shares after the transactions. He also holds 3,149 shares indirectly through a 401(k) plan and 711 shares in a Common Stock SERP account.

Positive

  • None.

Negative

  • None.
Insider Amodei Robert
Role Senior VP, Controller
Type Security Shares Price Value
Grant/Award Stock Option 1,130 $0.00 --
Grant/Award Common Stock 360 $212.77 $77K
Tax Withholding Common Stock 69 $212.77 $15K
holding 401k Plan -- -- --
holding Common Stock/Serp -- -- --
Holdings After Transaction: Stock Option — 1,130 shares (Direct); Common Stock — 44,290 shares (Direct); 401k Plan — 3,149 shares (Indirect, 401(K) Plan); Common Stock/Serp — 711 shares (Direct)
Footnotes (1)
  1. Constitutes restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. Represents withholding of shares to pay taxes. The stock options will become exercisable in three equal annual installments beginning on March 18, 2027
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Amodei Robert
(Last)(First)(Middle)
AMETEK, INC.
1100 CASSATT ROAD
(Street)
BERWYN PENNSYLVANIA 19312
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
AMETEK INC/ [ AME ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Senior VP, Controller
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/18/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock03/18/2026A(1)360A$212.7744,290D
Common Stock03/18/2026F(2)69D$212.7744,221D
401k Plan3,149I401(K) Plan
Common Stock/Serp711D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option$212.7703/18/2026A1,13003/18/2027(3)03/18/2036Common Stock1,130$01,130D
Explanation of Responses:
1. Constitutes restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan.
2. Represents withholding of shares to pay taxes.
3. The stock options will become exercisable in three equal annual installments beginning on March 18, 2027
Remarks:
/s/ Lynn Carino, attorney-in-fact for Mr. Amodei03/19/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What equity awards did AMETEK (AME) executive Robert Amodei receive?

Robert Amodei received two equity awards: 1,130 stock options and 360 restricted shares of AMETEK common stock. The restricted shares were issued under the 2020 Omnibus Incentive Compensation Plan and a portion was withheld to satisfy tax obligations.

What is the exercise price and vesting schedule of Robert Amodei’s new AMETEK options?

The new stock options have an exercise price of $212.77 per share and cover 1,130 AMETEK common shares. They become exercisable in three equal annual installments starting on March 18, 2027, and will remain outstanding until their expiration on March 18, 2036.

How many AMETEK (AME) shares does Robert Amodei own after these transactions?

After these transactions, Robert Amodei directly owns 44,221 shares of AMETEK common stock. He also has indirect ownership of 3,149 shares through a 401(k) plan and 711 shares in a Common Stock SERP account, according to the reported holdings data.

Why were some AMETEK shares withheld in Robert Amodei’s Form 4 filing?

Of the 360 AMETEK common shares granted, 69 shares were withheld to pay taxes. The filing describes this as a disposition to satisfy tax liability, which is a standard mechanism and not an open-market sale or discretionary stock transaction by the executive.

Under which plan were Robert Amodei’s AMETEK restricted shares granted?

The restricted shares granted to Robert Amodei were issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. This plan provides equity-based compensation, and the filing specifies that the 360-share grant constitutes restricted stock awarded pursuant to this incentive program.

Do Robert Amodei’s AMETEK option awards involve any immediate cash payment?

The option grant itself does not involve an immediate cash payment; the transaction price per option share is reported as $0.00. Any cash payment would occur only if and when Amodei exercises the options at the exercise price of $212.77 per share in the future.